| Year |
Citation |
Score |
| 2024 |
Sherr JL, Bergford S, Gal RL, Clements MA, Patton SR, Calhoun P, Beaulieu LC, Riddell MC. Exploring Factors That Influence Postexercise Glycemia in Youth With Type 1 Diabetes in the Real World: The Type 1 Diabetes Exercise Initiative Pediatric Study (T1DEXIP). Diabetes Care. PMID 38412033 DOI: 10.2337/dc23-2212 |
0.406 |
|
| 2024 |
Sherr JL, Laffel LM, Liu J, Wolf W, Bispham J, Chapman KS, Finan D, Titievsky L, Liu T, Hagan K, Gaglia J, Chandarana K, Bergenstal R, Pettus J. Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-Sectional Survey. Diabetes Care. PMID 38295397 DOI: 10.2337/dc23-1765 |
0.517 |
|
| 2024 |
DeSalvo DJ, Bode B, Forlenza GP, Laffel LM, Buckingham BA, Criego A, Schoelwer M, MacLeish SA, Sherr JL, Hansen D, Ly TT. Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod® 5 Automated Insulin Delivery System. Diabetes Technology & Therapeutics. PMID 38277156 DOI: 10.1089/dia.2023.0506 |
0.41 |
|
| 2024 |
Patton SR, Bergford S, Sherr JL, Gal RL, Calhoun P, Clements MA, Riddell MC, Martin CK. Postprandial Glucose Variability Following Typical Meals in Youth Living with Type 1 Diabetes. Nutrients. 16. PMID 38201991 DOI: 10.3390/nu16010162 |
0.379 |
|
| 2023 |
Riddell MC, Gal RL, Bergford S, Patton SR, Clements MA, Calhoun P, Beaulieu LC, Sherr JL. The Acute Effects of Real-World Physical Activity on Glycemia in Adolescents With Type 1 Diabetes: The Type 1 Diabetes Exercise Initiative Pediatric (T1DEXIP) Study. Diabetes Care. PMID 37922335 DOI: 10.2337/dc23-1548 |
0.43 |
|
| 2023 |
Criego A, Carlson AL, Brown S, Forlenza GP, Bode B, Levy C, Hansen D, Hirsch IB, Bergenstal RM, Sherr JL, Mehta S, Laffel LM, Shah VN, Bhargava A, Weinstock RS, et al. Two Years with a Tubeless AID System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics. PMID 37850941 DOI: 10.1089/dia.2023.0364 |
0.47 |
|
| 2023 |
Tobias DK, Merino J, Ahmad A, Aiken C, Benham JL, Bodhini D, Clark AL, Colclough K, Corcoy R, Cromer SJ, Duan D, Felton JL, Francis EC, Gillard P, Gingras V, ... ... Sherr JL, et al. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. Nature Medicine. 29: 2438-2457. PMID 37794253 DOI: 10.1038/s41591-023-02502-5 |
0.388 |
|
| 2023 |
Jacobsen LM, Sherr JL, Considine E, Chen A, Peeling SM, Hulsmans M, Charleer S, Urazbayeva M, Tosur M, Alamarie S, Redondo MJ, Hood KK, Gottlieb PA, Gillard P, Wong JJ, et al. Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review. Communications Medicine. 3: 132. PMID 37794113 DOI: 10.1038/s43856-023-00358-x |
0.465 |
|
| 2023 |
Pihoker C, Shulman DI, Forlenza GP, Kaiserman KB, Sherr JL, Thasher JR, Buckingham BA, Kipnes MS, Bode BW, Carlson AL, Lee S, Latif K, Lilenquist DR, Slover RH, Dai Z, et al. Safety and glycemic outcomes during the MiniMed™ advanced hybrid closed-loop (AHCL) system pivotal trial in children and adolescents with type 1 diabetes. Diabetes Technology & Therapeutics. PMID 37782145 DOI: 10.1089/dia.2023.0255 |
0.394 |
|
| 2023 |
Ylescupidez A, Speake C, Pietropaolo SL, Wilson DM, Steck AK, Sherr JL, Gaglia JL, Bender C, Lord S, Greenbaum CJ. OGTT metrics surpass continuous glucose monitoring data for T1D prediction in multiple-autoantibody-positive individuals. The Journal of Clinical Endocrinology and Metabolism. PMID 37572381 DOI: 10.1210/clinem/dgad472 |
0.421 |
|
| 2023 |
Nally LM, Sherr JL, Tichy E, Weyman K, Urban A, Shabanova V, McCollum S, Steffen A, Tamborlane WV, Van Name M. Impact of School-supervised Ultra-long-acting Basal Insulin Injections on Ketosis in Youth with T1D and Elevated Hemoglobin A1c: A Pilot Study. Diabetic Medicine : a Journal of the British Diabetic Association. e15123. PMID 37078999 DOI: 10.1111/dme.15123 |
0.377 |
|
| 2023 |
Galderisi A, Sherr JL. Answering clinically pertinent questions with real-world data from paediatric type 1 diabetes registries. The Lancet. Diabetes & Endocrinology. 11: 300-301. PMID 37004711 DOI: 10.1016/S2213-8587(23)00085-2 |
0.406 |
|
| 2023 |
McVean J, Forlenza GP, Beck RW, Bauza C, Bailey R, Buckingham B, DiMeglio LA, Sherr JL, Clements M, Neyman A, Evans-Molina C, Sims EK, Messer LH, Ekhlaspour L, McDonough R, et al. Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial. Jama. PMID 36826834 DOI: 10.1001/jama.2023.2063 |
0.416 |
|
| 2023 |
Wilson DM, Pietropaolo SL, Acevedo-Calado M, Huang S, Anyaiwe D, Scheinker D, Steck AK, Vasudevan MM, McKay SV, Sherr JL, Herold KC, Dunne JL, Greenbaum CJ, Lord SM, Haller MJ, et al. CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention Study. Diabetes Care. PMID 36730530 DOI: 10.2337/dc22-1297 |
0.633 |
|
| 2023 |
Huang J, Yeung AM, DuBord AY, Wolpert H, Jacobs PG, Lee WA, Drincic A, Spanakis EK, Sherr JL, Prahalad P, Fleming A, Hsiao VC, Kompala T, Lal RA, Fayfman M, et al. Diabetes Technology Meeting 2022. Journal of Diabetes Science and Technology. 19322968221148743. PMID 36704821 DOI: 10.1177/19322968221148743 |
0.528 |
|
| 2022 |
Sherr JL, Schoelwer M, Dos Santos TJ, Reddy L, Biester T, Galderisi A, van Dyk JC, Hilliard ME, Berget C, DiMeglio LA. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery. Pediatric Diabetes. 23: 1406-1431. PMID 36468192 DOI: 10.1111/pedi.13421 |
0.441 |
|
| 2022 |
Sherr JL, Heinemann L, Fleming GA, Bergenstal RM, Bruttomesso D, Hanaire H, Holl RW, Petrie JR, Peters AL, Evans M. Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetes Care. PMID 36202061 DOI: 10.2337/dci22-0018 |
0.503 |
|
| 2022 |
Sherr JL, Heinemann L, Fleming GA, Bergenstal RM, Bruttomesso D, Hanaire H, Holl RW, Petrie JR, Peters AL, Evans M. Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetologia. PMID 36198829 DOI: 10.1007/s00125-022-05744-z |
0.506 |
|
| 2022 |
Van Name M, Sherr J. When insulin isn't enough: targeting glucagon in type 1 diabetes. Nature Medicine. PMID 36192555 DOI: 10.1038/s41591-022-02019-3 |
0.486 |
|
| 2022 |
Sherr J. Seeking Simpler Solutions with Diabetes Technology. The New England Journal of Medicine. 387: 1228-1229. PMID 36170505 DOI: 10.1056/NEJMe2210686 |
0.34 |
|
| 2022 |
Phillip M, Nimri R, Bergenstal RM, Barnard-Kelly K, Danne T, Hovorka R, Kovatchev BP, Messer LH, Parkin CG, Ambler-Osborn L, Amiel SA, Bally L, Beck RW, Biester S, Biester T, ... ... Sherr JL, et al. Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice. Endocrine Reviews. PMID 36066457 DOI: 10.1210/endrev/bnac022 |
0.477 |
|
| 2022 |
Polonsky WH, Hood KK, Levy CJ, MacLeish SA, Hirsch IB, Brown SA, Bode BW, Carlson AL, Shah VN, Weinstock RS, Bhargava A, Jones TC, Aleppo G, Mehta SN, Laffel LM, ... ... Sherr JL, et al. How Introduction of Automated Insulin Delivery Systems May Influence Psychosocial Outcomes in Adults with Type 1 Diabetes: Findings from the First Investigation with the Omnipod® 5 System. Diabetes Research and Clinical Practice. 109998. PMID 35853530 DOI: 10.1016/j.diabres.2022.109998 |
0.483 |
|
| 2022 |
Sherr JL, Bode BW, Forlenza GP, Laffel LM, Schoelwer MJ, Buckingham BA, Criego AB, DeSalvo DJ, MacLeish SA, Hansen DW, Ly TT. Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial. Diabetes Care. PMID 35678724 DOI: 10.2337/dc21-2359 |
0.472 |
|
| 2022 |
Berget C, Sherr JL, DeSalvo DJ, Kingman RS, Stone SL, Brown SA, Nguyen A, Barrett L, Ly TT, Forlenza GP. Clinical Implementation of the Omnipod 5 Automated Insulin Delivery System: Key Considerations for Training and Onboarding People With Diabetes. Clinical Diabetes : a Publication of the American Diabetes Association. 40: 168-184. PMID 35669307 DOI: 10.2337/cd21-0083 |
0.503 |
|
| 2022 |
Buckingham B, Sherr J, Prestrelski SJ, Conoscenti V. Pharmacodynamics, pharmacokinetics, safety, and tolerability of a ready-to-use, room temperature, liquid stable glucagon administered via an autoinjector pen to youth with type 1 diabetes. Pediatric Diabetes. PMID 35562186 DOI: 10.1111/pedi.13360 |
0.412 |
|
| 2022 |
Xu NY, Nguyen KT, DuBord AY, Pickup J, Sherr JL, Teymourian H, Cengiz E, Ginsberg BH, Cobelli C, Ahn D, Bellazzi R, Bequette BW, Gandrud Pickett L, Parks L, Spanakis EK, et al. Diabetes Technology Meeting 2021. Journal of Diabetes Science and Technology. 19322968221090279. PMID 35499170 DOI: 10.1177/19322968221090279 |
0.491 |
|
| 2021 |
Dovc K, Van Name M, Jenko Bizjan B, Rusak E, Piona C, Yesiltepe-Mutlu G, Mentink R, Frontino G, Macedoni M, Ferreira SH, Serra-Caetano J, Galhardo J, Pelicand J, Silvestri F, Sherr J, et al. Continuous glucose monitoring use and glucose variability in very young children with type 1 diabetes (VibRate): A multinational prospective observational real-world cohort study. Diabetes, Obesity & Metabolism. 24: 564-569. PMID 34820985 DOI: 10.1111/dom.14607 |
0.424 |
|
| 2021 |
Carlson AL, Sherr JL, Shulman DI, Garg SK, Pop-Busui R, Bode BW, Lilenquist DR, Brazg RL, Kaiserman KB, Kipnes MS, Thasher JR, Reed JHC, Slover RH, Philis-Tsimikas A, Christiansen M, et al. Safety and glycemic outcomes during the MiniMed™ Advanced Hybrid Closed-Loop system pivotal trial in adolescents and adults with type 1 diabetes. Diabetes Technology & Therapeutics. PMID 34694909 DOI: 10.1089/dia.2021.0319 |
0.372 |
|
| 2021 |
Nguyen KT, Xu NY, Zhang JY, Shang T, Basu A, Bergenstal RM, Castorino K, Chen KY, Kerr D, Koliwad SK, Laffel LM, Mathioudakis N, Midyett LK, Miller JD, Nichols JH, ... ... Sherr JL, et al. Continuous Ketone Monitoring Consensus Report 2021. Journal of Diabetes Science and Technology. 19322968211042656. PMID 34605694 DOI: 10.1177/19322968211042656 |
0.423 |
|
| 2021 |
DuBose S, Bauza C, Verdejo A, Beck RW, Bergenstal RM, Sherr J. Real-world, Patient-Reported and Clinic Data from Individuals with Type 1 Diabetes using the MiniMed 670G Hybrid Closed Loop System. Diabetes Technology & Therapeutics. PMID 34524023 DOI: 10.1089/dia.2021.0176 |
0.425 |
|
| 2021 |
Perkins BA, Sherr JL, Mathieu C. Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automation. Science (New York, N.Y.). 373: 522-527. PMID 34326234 DOI: 10.1126/science.abg4502 |
0.448 |
|
| 2021 |
Sherr JL, Schwandt A, Phelan H, Clements MA, Holl RW, Benitez-Aguirre PZ, Miller KM, Woelfle J, Dover T, Maahs DM, Fröhlich-Reiterer E, Craig ME. Hemoglobin A1c Patterns of Youth With Type 1 Diabetes 10 Years Post Diagnosis From 3 Continents. Pediatrics. PMID 34315809 DOI: 10.1542/peds.2020-048942 |
0.447 |
|
| 2021 |
Shang T, Zhang JY, Bequette BW, Raymond JK, Coté G, Sherr JL, Castle J, Pickup J, Pavlovic Y, Espinoza J, Messer LH, Heise T, Mendez CE, Kim S, Ginsberg BH, et al. Diabetes Technology Meeting 2020. Journal of Diabetes Science and Technology. 15: 916-960. PMID 34196228 DOI: 10.1177/19322968211016480 |
0.48 |
|
| 2021 |
Nally LM, Wagner J, Sherr J, Tichy E, Weyman K, Ginley MK, Zajac K, Desousa M, Shabanova V, Petry NM, Tamborlane WV, Van Name M. A Pilot Study of Youth With Type 1 Diabetes Initiating Use of a Hybrid Closed-Loop System While Receiving a Behavioral Economics Intervention. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 27: 545-551. PMID 34120699 DOI: 10.1016/j.eprac.2020.11.017 |
0.417 |
|
| 2021 |
Grunberger G, Sherr J, Allende M, Blevins T, Bode B, Handelsman Y, Hellman R, Lajara R, Roberts VL, Rodbard D, Stec C, Unger J. American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 27: 505-537. PMID 34116789 DOI: 10.1016/j.eprac.2021.04.008 |
0.364 |
|
| 2021 |
Brown SA, Forlenza GP, Bode BW, Pinsker JE, Levy CJ, Criego AB, Hansen DW, Hirsch IB, Carlson AL, Bergenstal RM, Sherr JL, Mehta SN, Laffel LM, Shah VN, Bhargava A, et al. Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes. Diabetes Care. PMID 34099518 DOI: 10.2337/dc21-0172 |
0.516 |
|
| 2020 |
Polsky S, Foster NC, DuBose SN, Agarwal S, Lyons S, Peters AL, Uwaifo GI, DiMeglio LA, Sherr JL, Levy CJ. Incident diabetes complications among women with type 1 diabetes based on parity. The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 1-6. PMID 33280471 DOI: 10.1080/14767058.2020.1858278 |
0.425 |
|
| 2020 |
Laffel LM, Kanapka LG, Beck RW, Bergamo K, Clements MA, Criego A, DeSalvo DJ, Goland R, Hood K, Liljenquist D, Messer LH, Monzavi R, Mouse TJ, Prahalad P, Sherr J, et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. Jama. 323: 2388-2396. PMID 32543683 DOI: 10.1001/Jama.2020.6940 |
0.513 |
|
| 2020 |
Suico JG, Hövelmann U, Zhang S, Shen T, Bergman B, Sherr J, Zijlstra E, Frier BM, Plum-Mörschel L. Glucagon Administration by Nasal and Intramuscular Routes in Adults With Type 1 Diabetes During Insulin-Induced Hypoglycaemia: A Randomised, Open-Label, Crossover Study. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders. PMID 32514794 DOI: 10.1007/S13300-020-00845-7 |
0.51 |
|
| 2020 |
DuBose SN, Li Z, Sherr JL, Beck RW, Tamborlane WV, Shah VN. Effect of Exercise and Meals on Continuous Glucose Monitor Data in Healthy Individuals Without Diabetes. Journal of Diabetes Science and Technology. 1932296820905904. PMID 32064911 DOI: 10.1177/1932296820905904 |
0.492 |
|
| 2020 |
Shah VN, Bailey R, Wu M, Foster NC, Pop-Busui R, Katz M, Crandall J, Bacha F, Nadeau K, Libman I, Hiers P, Mizokami-Stout K, DiMeglio LA, Sherr J, Pratley R, et al. Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry. The Journal of Clinical Endocrinology and Metabolism. PMID 31955209 DOI: 10.1210/Clinem/Dgaa015 |
0.446 |
|
| 2020 |
Rickels MR, Evans-Molina C, Bahnson HT, Ylescupidez A, Nadeau KJ, Hao W, Clements MA, Sherr JL, Pratley RE, Hannon TS, Shah VN, Miller KM, Greenbaum CJ. High residual C-peptide likely contributes to glycemic control in type 1 diabetes. The Journal of Clinical Investigation. PMID 31895699 DOI: 10.1172/Jci134057 |
0.422 |
|
| 2020 |
CARLSON AL, BODE BW, BRAZG RL, CHRISTIANSEN MP, GARG SK, KAISERMAN K, KIPNES M, LILJENQUIST DR, PHILIS-TSIMIKAS A, POP-BUSUI R, SHERR J, SHULMAN DI, SINGH KK, SLOVER RH, THRASHER J, et al. 97-LB: Safety and Glycemic Outcomes of the MiniMed Advanced Hybrid Closed-Loop (AHCL) System in Subjects with T1D Diabetes. 69: 97-LB. DOI: 10.2337/Db20-97-Lb |
0.351 |
|
| 2020 |
Sherr J, Schwandt A, Phelan H, Clements MA, Holl RW, Benitez-Aguirre PZ, Miller K, Woelfle J, Dover T, Maahs DM, Fröhlich-Reiterer E, Craig ME. 1580-P: Hemoglobin A1c (HbA1c) Trajectories of Youth with Type 1 Diabetes (T1D) over 10 Years Postdiagnosis from Three Continents Diabetes. 69. DOI: 10.2337/Db20-1580-P |
0.524 |
|
| 2020 |
Riddell M, Li Z, Gal RL, Mazzuoccolo A, Greene E, Calhoun P, Beaulieu LC, Clements MA, Sherr J, Patton SR, Beck R. 1304-P: Glycemic Trends in a Hockey Camp for Youth with Type 1 Diabetes (T1D) Diabetes. 69. DOI: 10.2337/Db20-1304-P |
0.533 |
|
| 2020 |
Sherr J, Buckingham BA, Forlenza GP, Galderisi A, Ekhlaspour L, Wadwa RP, Zgorski M, Kingman RS, Berget C, Lee JB, Oconnor JB, Dumais B, Vienneau T, Huyett LM, Ly TT. 1296-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Children Aged 2-12 Years without Increasing Risk of Hypoglycemia Diabetes. 69. DOI: 10.2337/Db20-1296-P |
0.334 |
|
| 2019 |
Sherr J, Buckingham BA, Forlenza G, Galderisi A, Ekhlaspour L, Wadwa RP, Carria L, Hsu LJ, Berget CL, Peyser TA, Lee JB, O'Connor J, Dumais B, Huyett LM, Layne JE, et al. Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions. Diabetes Technology & Therapeutics. PMID 31596130 DOI: 10.1089/Dia.2019.0286 |
0.446 |
|
| 2019 |
Galderisi A, Sherr JL. A Technological Revolution: The Integration of New Treatments to Manage Type 1 Diabetes. Pediatric Annals. 48: e311-e318. PMID 31426099 DOI: 10.3928/19382359-20190725-03 |
0.582 |
|
| 2019 |
Shah VN, DuBose SN, Li Z, Beck RW, Petesrs AL, Weinstock RS, Kruger D, Tansey M, Sparling D, Woerner S, Vendrame F, Bergenstal R, Tamborlane WV, Watson SE, Sherr J. Continuous Glucose Monitoring Profiles in Healthy Non-Diabetic Participants: A Multicenter Prospective Study. The Journal of Clinical Endocrinology and Metabolism. PMID 31127824 DOI: 10.1210/Jc.2018-02763 |
0.598 |
|
| 2019 |
Elahi S, Patel AD, Guandalini C, Steffen A, Sherr J, Tamborlane WV, Van Name MA. IMPACT OF SWITCHING YOUTH WITH DIABETES TO INSULIN DEGLUDEC IN CLINICAL PRACTICE. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 25: 226-229. PMID 30913005 DOI: 10.4158/Ep-2018-0417 |
0.601 |
|
| 2019 |
Nally LM, Sherr JL, Van Name MA, Patel AD, Tamborlane WV. Pharmacologic Treatment Options for Type 1 Diabetes: What's New? Expert Review of Clinical Pharmacology. PMID 30892094 DOI: 10.1080/17512433.2019.1597705 |
0.561 |
|
| 2019 |
Hirsch IB, Sherr JL, Hood KK. Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes. Diabetes Care. 42: 345-348. PMID 30787056 DOI: 10.2337/Dci18-0040 |
0.509 |
|
| 2019 |
Siebel S, Galderisi A, Patel NS, Carria LR, Tamborlane WV, Sherr JL. Reversal of Ketosis in Type 1 Diabetes Is Not Adversely Affected by SGLT2 Inhibitor Therapy. Diabetes Technology & Therapeutics. PMID 30688521 DOI: 10.1089/Dia.2018.0356 |
0.503 |
|
| 2019 |
Polsky S, Foster NC, Dubose S, Agarwal S, Lyons S, Peters AL, Uwaifo GI, Dimeglio L, Sherr J, Levy CJ. 2418-PUB: Incident Diabetes Complications among Women with T1D Based on Parity Diabetes. 68. DOI: 10.2337/Db19-2418-Pub |
0.435 |
|
| 2019 |
Levy CJ, Foster NC, Dubose S, Agarwal S, Lyons S, Peters AL, Uwaifo GI, Dimeglio L, Sherr J, Polsky S. 1424-P: Changes in Device Uptake and Glycemic Control among Pregnant Women with Type 1 Diabetes: Data from the T1D Exchange Diabetes. 68. DOI: 10.2337/Db19-1424-P |
0.45 |
|
| 2019 |
SHERR J, FOSTER NC, BETHIN K, FOX LA, MASTRANDREA LD, NATHAN BM, REDONDO MJ, SILVERSTEIN J, SIMMONS J, CLEMENTS MA, TAMBORLANE WV, THRAILKILL KM, WONG JC, WOOD J. 1355-P: HbA1c Trajectories from Time of Diagnosis in Youth with T1D Diabetes. 68: 1355-P. DOI: 10.2337/Db19-1355-P |
0.326 |
|
| 2018 |
Galderisi A, Sherr JL. Enlarging the loop: closed-loop insulin delivery for type 1 diabetes. Lancet (London, England). PMID 30292579 DOI: 10.1016/S0140-6736(18)32329-8 |
0.591 |
|
| 2018 |
Shah VN, Wu M, Polsky S, Snell-Bergeon JK, Sherr JL, Cengiz E, DiMeglio LA, Pop-Busui R, Mizokami-Stout K, Foster NC, Beck RW. Gender differences in diabetes self-care in adults with type 1 diabetes: Findings from the T1D Exchange clinic registry. Journal of Diabetes and Its Complications. PMID 30121205 DOI: 10.1016/J.Jdiacomp.2018.08.009 |
0.542 |
|
| 2018 |
Slover RH, Tryggestad JB, DiMeglio LA, Fox LA, Bode BW, Bailey TS, Brazg R, Christiansen MP, Sherr JL, Tsalikian E, Kaiserman KB, Sullivan A, Huang S, Shin J, Lee SW, et al. Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes. Diabetes Technology & Therapeutics. PMID 30063162 DOI: 10.1089/Dia.2018.0109 |
0.53 |
|
| 2018 |
Sherr JL, Tauschman M, Battelino T, de Bock M, Forlenza G, Roman R, Hood KK, Maahs DM. ISPAD Clinical Practice Consensus Guidelines 2018 Diabetes Technologies. Pediatric Diabetes. PMID 30039513 DOI: 10.1111/Pedi.12731 |
0.545 |
|
| 2018 |
Sherr JL. Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults. Diabetes Care. PMID 29936422 DOI: 10.2337/Dci18-0003 |
0.511 |
|
| 2018 |
DeSalvo DJ, Miller KM, Hermann JM, Maahs DM, Hofer SE, Clements MA, Lilienthal E, Sherr JL, Tauschmann M, Holl RW. Continuous Glucose Monitoring (CGM) and Glycemic Control Among Youth with Type 1 Diabetes (T1D): International comparison from the T1D Exchange and DPV Initiative. Pediatric Diabetes. PMID 29923262 DOI: 10.1111/Pedi.12711 |
0.527 |
|
| 2018 |
Messer LH, Forlenza GP, Sherr JL, Wadwa RP, Buckingham BA, Weinzimer SA, Maahs DM, Slover RH. Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System. Diabetes Care. PMID 29444895 DOI: 10.2337/Dc17-1682 |
0.408 |
|
| 2018 |
Buckingham BA, Sherr J, Forlenza GP, Peyser TA, Lee JB, Oconnor JB, Dumais B, Huyett LM, Layne JE, Ly TT. Safety and Performance of the Omnipod® Hybrid Closed-Loop System in Adults with Type 1 Diabetes over Five Days Under Free-Living Conditions Diabetes. 67. DOI: 10.2337/Db18-207-Or |
0.387 |
|
| 2018 |
MEHTA SN, WU M, FOSTER NC, POP-BUSUI R, KATZ M, CRANDALL JP, BACHA F, NADEAU KJ, LIBMAN I, HIERS P, MIZOKAMI-STOUT KR, DIMEGLIO L, SHERR J, PRATLEY RE, AGARWAL S, et al. Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes (T1D) Diabetes. 67: 15-LB. DOI: 10.2337/Db18-15-Lb |
0.424 |
|
| 2018 |
Sherr J, Forlenza GP, Buckingham B, Peyser TA, Lee JB, Oconnor JB, Dumais B, Huyett LM, Layne JE, Ly TT. Safety and Performance of the Omnipod® Hybrid Closed-Loop System in Children Aged 6-12 Years with Type 1 Diabetes over Five Days Under Free-Living Conditions Diabetes. 67. DOI: 10.2337/Db18-1377-P |
0.389 |
|
| 2018 |
Forlenza GP, Buckingham B, Sherr J, Peyser TA, Lee JB, Oconnor JB, Dumais B, Huyett LM, Layne JE, Ly TT. Safety and Performance of the Omnipod® Hybrid Closed-Loop System in Adolescents with Type 1 Diabetes over Five Days Under Free-Living Conditions Diabetes. 67. DOI: 10.2337/Db18-1376-P |
0.388 |
|
| 2018 |
Siebel S, Patel NS, Galderisi A, Carria LR, Tamborlane WV, Sherr J. Suppression of Ketogenesis in Type 1 Diabetes Is Not Delayed by SGLT2 Inhibitor Therapy Diabetes. 67. DOI: 10.2337/Db18-117-Lb |
0.462 |
|
| 2018 |
Suico J, Hövelmann U, Zhang S, Shen T, Bergman B, Sherr J, Zijlstra E, Frier B, Plum-Morschel L. Nasal Glucagon: Potentially Viable Alternative to Treat Insulin-Induced Hypoglycemia in Adults with Type 1 Diabetes Canadian Journal of Diabetes. 42. DOI: 10.1016/J.Jcjd.2018.08.162 |
0.593 |
|
| 2017 |
Galderisi A, Sherr J, VanName M, Carria L, Zgorski M, Tichy E, Weyman K, Cengiz E, Weinzimer S, Tamborlane W. Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes. The Journal of Clinical Endocrinology and Metabolism. 103: 1088-1094. PMID 29211871 DOI: 10.1210/Jc.2017-02265 |
0.394 |
|
| 2017 |
Patel NS, Van Name MA, Cengiz E, Carria LR, Weinzimer SA, Tamborlane WV, Sherr JL. Altered Patterns of Early Metabolic Decompensation in Type 1 Diabetes During Treatment with a SGLT2 Inhibitor: An Insulin Pump Suspension Study. Diabetes Technology & Therapeutics. PMID 29068709 DOI: 10.1089/dia.2017.0267 |
0.515 |
|
| 2017 |
Ang KH, Sherr JL. Moving beyond subcutaneous insulin: the application of adjunctive therapies to the treatment of type 1 diabetes. Expert Opinion On Drug Delivery. 14: 1113-1131. PMID 28774208 DOI: 10.1080/17425247.2017.1360862 |
0.569 |
|
| 2017 |
Messer LH, Forlenza GP, Wadwa RP, Weinzimer SA, Sherr JL, Hood KK, Buckingham BA, Slover RH, Maahs DM. The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration. Pediatric Diabetes. PMID 28656656 DOI: 10.1111/Pedi.12535 |
0.426 |
|
| 2017 |
Haymond MW, DuBose SN, Rickels MR, Wolpert H, Shah VN, Sherr JL, Weinstock RS, Agarwal S, Verdejo AS, Cummins MJ, Newswanger B, Beck RW. Efficacy and Safety of Mini-dose Glucagon for Treatment of Non-severe Hypoglycemia in Adults with Type 1 Diabetes. The Journal of Clinical Endocrinology and Metabolism. PMID 28591776 DOI: 10.1210/Jc.2017-00591 |
0.457 |
|
| 2017 |
Erie C, Van Name MA, Weyman K, Weinzimer SA, Finnegan J, Sikes K, Tamborlane WV, Sherr JL. Schooling diabetes: Use of continuous glucose monitoring and remote monitors in the home and school settings. Pediatric Diabetes. PMID 28303678 DOI: 10.1111/Pedi.12518 |
0.521 |
|
| 2016 |
Sherr JL, Boyle CT, Miller KM, Beck RW, Tamborlane WV. No Summer Vacation From Diabetes: Glycemic Control in Pediatric Participants in the T1D Exchange Registry Based on Time of Year. Diabetes Care. PMID 27703027 DOI: 10.2337/Dc16-1522 |
0.524 |
|
| 2016 |
Rickels MR, Ruedy KJ, Foster NC, Piché CA, Dulude H, Sherr JL, Tamborlane WV, Bethin KE, DiMeglio LA, Wadwa RP, Ahmann AJ, Haller MJ, Nathan BM, Marcovina SM, Rampakakis E, et al. Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264-270. Diabetes Care. 39: e193-4. PMID 27660135 DOI: 10.2337/Dci16-0025 |
0.571 |
|
| 2016 |
Sherr JL, Patel NS, Michaud CI, Palau-Collazo MM, Van Name MA, Tamborlane WV, Cengiz E, Carria LR, Tichy EM, Weinzimer SA. Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide. Diabetes Care. PMID 27208332 DOI: 10.2337/Dc16-0089 |
0.446 |
|
| 2016 |
Ly TT, Weinzimer SA, Maahs DM, Sherr JL, Roy A, Grosman B, Cantwell M, Kurtz N, Carria L, Messer L, von Eyben R, Buckingham BA. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance. Pediatric Diabetes. PMID 27191182 DOI: 10.1111/Pedi.12399 |
0.538 |
|
| 2016 |
Sherr JL, Ruedy KJ, Foster NC, Piché CA, Dulude H, Rickels MR, Tamborlane WV, Bethin KE, DiMeglio LA, Fox LA, Wadwa RP, Schatz DA, Nathan BM, Marcovina SM, Rampakakis E, et al. Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes. Diabetes Care. PMID 26884472 DOI: 10.2337/Dc15-1606 |
0.436 |
|
| 2015 |
Rickels MR, Ruedy KJ, Foster NC, Piché CA, Dulude H, Sherr JL, Tamborlane WV, Bethin KE, DiMeglio LA, Wadwa RP, Ahmann AJ, Haller MJ, Nathan BM, Marcovina SM, Rampakakis E, et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care. PMID 26681725 DOI: 10.2337/Dc15-1498 |
0.579 |
|
| 2015 |
Sherr JL, Hermann JM, Campbell F, Foster NC, Hofer SE, Allgrove J, Maahs DM, Kapellen TM, Holman N, Tamborlane WV, Holl RW, Beck RW, Warner JT. Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries. Diabetologia. PMID 26546085 DOI: 10.1007/S00125-015-3790-6 |
0.545 |
|
| 2014 |
Sherr J, Tsalikian E, Fox L, Buckingham B, Weinzimer S, Tamborlane WV, White NH, Arbelaez AM, Kollman C, Ruedy KJ, Cheng P, Beck RW. Evolution of abnormal plasma glucagon responses to mixed-meal feedings in youth with type 1 diabetes during the first 2 years after diagnosis. Diabetes Care. 37: 1741-4. PMID 24696460 DOI: 10.2337/Dc13-2612 |
0.417 |
|
| 2014 |
Cengiz E, Weinzimer SA, Sherr JL, Tichy EM, Carria L, Cappiello D, Steffen A, Tamborlane WV. Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warming. Diabetes Technology & Therapeutics. 16: 20-5. PMID 24367934 DOI: 10.1089/dia.2013.0187 |
0.402 |
|
| 2014 |
Sherr JL, Palau Collazo M, Cengiz E, Michaud C, Carria L, Steffen AT, Weyman K, Zgorski M, Tichy E, Tamborlane WV, Weinzimer SA. Safety of nighttime 2-hour suspension of Basal insulin in pump-treated type 1 diabetes even in the absence of low glucose. Diabetes Care. 37: 773-9. PMID 24170766 DOI: 10.2337/Dc13-1608 |
0.545 |
|
| 2014 |
Sherr JL, Ghazi T, Wurtz A, Rink L, Herold KC. Characterization of residual β cell function in long-standing type 1 diabetes. Diabetes/Metabolism Research and Reviews. 30: 154-62. PMID 24115337 DOI: 10.1002/Dmrr.2478 |
0.661 |
|
| 2014 |
Arbelaez AM, Xing D, Cryer PE, Kollman C, Beck RW, Sherr J, Ruedy KJ, Tamborlane WV, Mauras N, Tsalikian E, Wilson DM, White NH. Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus. Pediatric Diabetes. 15: 127-34. PMID 23992543 DOI: 10.1111/Pedi.12070 |
0.576 |
|
| 2014 |
Ghazi T, Rink L, Sherr JL, Herold KC. Acute metabolic effects of exenatide in patients with type 1 diabetes with and without residual insulin to oral and intravenous glucose challenges. Diabetes Care. 37: 210-6. PMID 23939544 DOI: 10.2337/Dc13-1169 |
0.684 |
|
| 2013 |
Tamborlane WV, Sherr JL. Diabetes: Insulin pumps in children with T1DM--we told you so. Nature Reviews. Endocrinology. 9: 629-30. PMID 24080733 DOI: 10.1038/Nrendo.2013.190 |
0.562 |
|
| 2013 |
Sherr JL, Cengiz E, Palerm CC, Clark B, Kurtz N, Roy A, Carria L, Cantwell M, Tamborlane WV, Weinzimer SA. Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetes. Diabetes Care. 36: 2909-14. PMID 23757427 DOI: 10.2337/Dc13-0010 |
0.504 |
|
| 2013 |
Sherr J, Xing D, Ruedy KJ, Beck RW, Kollman C, Buckingham B, White NH, Fox L, Tsalikian E, Weinzimer S, Arbelaez AM, Tamborlane WV. Lack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetes. Diabetes Care. 36: 1470-6. PMID 23288858 DOI: 10.2337/Dc12-1697 |
0.436 |
|
| 2013 |
Cengiz E, Weinzimer SA, Sherr JL, Tichy E, Martin M, Carria L, Steffen A, Tamborlane WV. Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device. Pediatric Diabetes. 14: 168-73. PMID 23107353 DOI: 10.1111/Pedi.12001 |
0.469 |
|
| 2013 |
Herold KC, Gitelman SE, Willi SM, Gottlieb PA, Waldron-Lynch F, Devine L, Sherr J, Rosenthal SM, Adi S, Jalaludin MY, Michels AW, Dziura J, Bluestone JA. Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial. Diabetologia. 56: 391-400. PMID 23086558 DOI: 10.1007/S00125-012-2753-4 |
0.622 |
|
| 2012 |
Ruiz JL, Sherr JL, Cengiz E, Carria L, Roy A, Voskanyan G, Tamborlane WV, Weinzimer SA. Effect of insulin feedback on closed-loop glucose control: a crossover study. Journal of Diabetes Science and Technology. 6: 1123-30. PMID 23063039 DOI: 10.1177/193229681200600517 |
0.408 |
|
| 2012 |
Weinzimer SA, Sherr JL, Cengiz E, Kim G, Ruiz JL, Carria L, Voskanyan G, Roy A, Tamborlane WV. Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes. Diabetes Care. 35: 1994-9. PMID 22815298 DOI: 10.1089/Dia.2014.1504 |
0.522 |
|
| 2012 |
Cengiz E, Swan KL, Tamborlane WV, Sherr JL, Martin M, Weinzimer SA. The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin. Diabetes Care. 35: 690-2. PMID 22374642 DOI: 10.2337/Dc11-0732 |
0.507 |
|
| 2012 |
Sherr J, Tamborlane WV, Xing D, Tsalikian E, Mauras N, Buckingham B, White NH, Arbelaez AM, Beck RW, Kollman C, Ruedy K. Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function. Diabetes Care. 35: 817-20. PMID 22323414 DOI: 10.2337/Dc11-2190 |
0.465 |
|
| 2012 |
Sherr JL, Weinzimer SA. Diabetes types 1 and 2 in the pediatric population. Pediatric Annals. 41: e1-7. PMID 22299623 DOI: 10.3928/00904481-20120110-09 |
0.487 |
|
| 2011 |
Cengiz E, Sherr JL, Weinzimer SA, Tamborlane WV. New-generation diabetes management: glucose sensor-augmented insulin pump therapy. Expert Review of Medical Devices. 8: 449-58. PMID 21728731 DOI: 10.1586/Erd.11.22 |
0.556 |
|
| 2011 |
Cengiz E, Sherr JL, Erkin-Cakmak A, Weinzimer SA, Burke EN, Sikes KA, Urban AD, Tamborlane WV. A bridge to insulin pump therapy: twice-daily regimen with NPH and detemir insulins during initial treatment of youth with type 1 diabetes mellitus. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 17: 862-6. PMID 21550949 DOI: 10.4158/Ep11031.Or |
0.523 |
|
| 2009 |
Sherr J, Cengiz E, Tamborlane WV. From pumps to prevention: recent advances in the treatment of type 1 diabetes. Drug Discovery Today. 14: 973-81. PMID 19580883 DOI: 10.1016/J.Drudis.2009.06.011 |
0.576 |
|
| 2008 |
Sherr J, Tamborlane WV. Past, present, and future of insulin pump therapy: better shot at diabetes control. The Mount Sinai Journal of Medicine, New York. 75: 352-61. PMID 18729180 DOI: 10.1002/Msj.20055 |
0.534 |
|
| 2008 |
Sherr J, Sosenko J, Skyler JS, Herold KC. Prevention of type 1 diabetes: the time has come. Nature Clinical Practice. Endocrinology & Metabolism. 4: 334-43. PMID 18446141 DOI: 10.1038/Ncpendmet0832 |
0.642 |
|
| Show low-probability matches. |